Skip to content

Cognex CGNX Research, Development and Engineering Expenses — Stock-Based Comp

Similar metrics at other companies

TG Therapeutics logo
TGTXNon Cash Compensation Research And Development Expenses
$4.88M+46.4%
Arrowhead Research logo
ARWROperating Segment — Stock compensation
$8.37M+2.9%
Charles River Laboratories logo
CRLCorporate Non — Allocated Share Based Compensation Expense
$6.99M+25.2%
EFC
EFCEquity-based compensation expense
$910.5K+24.0%
Gen Digital Inc. logo
GENMaterial Reconciling Items — Allocated Share Based Compensation Expense
$55M-56.0%
Charles River Laboratories logo
CRLCorporate — Allocated Share Based Compensation Expense
$6.44M+39.4%

Other financials

Income statement

See full
Revenue$268.4M+24.3%
Gross profit$190.9M+32.3%
Operating income$59.9M+129%
Net income$51.7M+119%
EPS (diluted)$0.31+121%

Balance sheet

See full
Cash & equivalents$237.3M+65.1%
Total debt$74.0M+0.4%
Total equity$1.5B+2.3%
Total assets$2.0B+3.8%

Cash flow

See full
Operating cash flow$45.1M+11.3%
CapEx$2.8M+10.2%
Free cash flow$42.3M+11.4%

Valuation

See full
Market cap$11B+61.9%
Enterprise value$10.84B+60.9%
P/E77.2×+19.5×
P/S10.5×+3.1×

Profitability

See full
Gross margin68%-0.3pp
Operating margin18.8%+5.0pp
Net margin13.6%+0.8pp
FCF margin23%+5.4pp

Returns & leverage

See full
Return on equity9.7%+1.7pp
Debt / equity0.1×0.0×
Current ratio3.6×+0.5×

Where this comes from

Reported directly by Cognex in its filing.

Tagged under the XBRL concept us-gaap:AllocatedShareBasedCompensationExpense.

The official record: Cognex’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cognex's research, development and engineering expenses — stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cognex's research, development and engineering expenses — stock-based comp?
Cognex (CGNX) reported research, development and engineering expenses — stock-based comp of $5.09M in Q1 2026.
How has Cognex's research, development and engineering expenses — stock-based comp changed year-over-year?
Cognex's research, development and engineering expenses — stock-based comp increased by 8.5% year-over-year, from $4.7M to $5.09M.
What is the long-term trend for Cognex's research, development and engineering expenses — stock-based comp?
Over 3 years (2022 to 2025), Cognex's research, development and engineering expenses — stock-based comp has grown at a -4.7% compound annual growth rate (CAGR), from $17.69M to $15.34M.
What does research, development and engineering expenses — stock-based comp mean?
The non-cash expense of stock-based awards granted to the R&D team.
How do you interpret research, development and engineering expenses — stock-based comp?
An increase indicates a higher reliance on equity for talent retention, which may impact future share dilution, while a decrease suggests a shift toward cash-based compensation.
How does research, development and engineering expenses — stock-based comp compare across companies?
Standard line item in 'Stock-based Compensation' disclosures for technology companies.